Global Endocrinology Drugs Market by Type (Diabetes Drugs, Testosterone Replacement Drugs, Human Growth Hormone Drugs, Thyroid Hormone Disorder Drugs), By Application (Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Endocrinology Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Endocrinology Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Endocrinology Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Endocrinology Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Endocrinology Drugs Market Size & Forecast, 2018-2028
4.5.1 Endocrinology Drugs Market Size and Y-o-Y Growth
4.5.2 Endocrinology Drugs Market Absolute $ Opportunity
Chapter 5 Global Endocrinology Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Endocrinology Drugs Market Size Forecast by Type
5.2.1 Diabetes Drugs
5.2.2 Testosterone Replacement Drugs
5.2.3 Human Growth Hormone Drugs
5.2.4 Thyroid Hormone Disorder Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Endocrinology Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Endocrinology Drugs Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Commercial Laboratories
6.2.3 Ambulatory Care Centres
6.2.4 Other Setting
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Endocrinology Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Endocrinology Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Endocrinology Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Endocrinology Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Endocrinology Drugs Market Size Forecast by Type
9.6.1 Diabetes Drugs
9.6.2 Testosterone Replacement Drugs
9.6.3 Human Growth Hormone Drugs
9.6.4 Thyroid Hormone Disorder Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Endocrinology Drugs Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Commercial Laboratories
9.10.3 Ambulatory Care Centres
9.10.4 Other Setting
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Endocrinology Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Endocrinology Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Endocrinology Drugs Market Size Forecast by Type
10.6.1 Diabetes Drugs
10.6.2 Testosterone Replacement Drugs
10.6.3 Human Growth Hormone Drugs
10.6.4 Thyroid Hormone Disorder Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Endocrinology Drugs Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Commercial Laboratories
10.10.3 Ambulatory Care Centres
10.10.4 Other Setting
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Endocrinology Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Endocrinology Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Endocrinology Drugs Market Size Forecast by Type
11.6.1 Diabetes Drugs
11.6.2 Testosterone Replacement Drugs
11.6.3 Human Growth Hormone Drugs
11.6.4 Thyroid Hormone Disorder Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Endocrinology Drugs Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Commercial Laboratories
11.10.3 Ambulatory Care Centres
11.10.4 Other Setting
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Endocrinology Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Endocrinology Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Endocrinology Drugs Market Size Forecast by Type
12.6.1 Diabetes Drugs
12.6.2 Testosterone Replacement Drugs
12.6.3 Human Growth Hormone Drugs
12.6.4 Thyroid Hormone Disorder Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Endocrinology Drugs Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Commercial Laboratories
12.10.3 Ambulatory Care Centres
12.10.4 Other Setting
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Endocrinology Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Endocrinology Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Endocrinology Drugs Market Size Forecast by Type
13.6.1 Diabetes Drugs
13.6.2 Testosterone Replacement Drugs
13.6.3 Human Growth Hormone Drugs
13.6.4 Thyroid Hormone Disorder Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Endocrinology Drugs Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Commercial Laboratories
13.10.3 Ambulatory Care Centres
13.10.4 Other Setting
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Endocrinology Drugs Market: Competitive Dashboard
14.2 Global Endocrinology Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AbbVie
14.3.2 AstraZeneca
14.3.3 Eli Lilly
14.3.4 Merck
14.3.5 Novo Nordisk
14.3.6 Sanofi